WHO grants prequalification to Cervarix®: GSK’s vaccine to help combat cervical cancer in developing nations

The WHO decision is necessary for UN agencies and the GAVI Alliance to purchase the vaccine in partnership with developing countries and will help speed access to Cervarix globally.